The cyclophilins

Overview of attention for article published in Genome Biology, June 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

So far, Altmetric has seen 5 news stories from 2 outlets.

Dosing is underway in an open-label Phase 2 clinical trial, AMBITION, evaluating Hepion Pharmaceuticals' (NASDAQ: HEPA ) lead…

Nano cap Hepion Pharmaceuticals (NASDAQ: HEPA ) announces encouraging results from a Japan-based lab study evaluating lead…

Thinly traded nano cap Hepion Pharmaceuticals (NASDAQ: HEPA ) is up 80% premarket on increased volume in reaction to…

Thinly traded nano cap ContraVir Pharmaceuticals (NASDAQ:CTRV) is up 139% premarket on increased volume in reaction to positive…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 1 additional news stories.